Dentium CO., LTD (KRX:145720)
71,500
+900 (1.27%)
Feb 21, 2025, 9:00 AM KST
Dentium CO., LTD Revenue
Dentium CO., LTD had revenue of 94.68B KRW in the quarter ending September 30, 2024, with 0.96% growth. This brings the company's revenue in the last twelve months to 413.29B, up 13.86% year-over-year. In the year 2023, Dentium CO., LTD had annual revenue of 393.19B with 10.49% growth.
Revenue (ttm)
413.29B
Revenue Growth
+13.86%
P/S Ratio
1.49
Revenue / Employee
516.62M
Employees
800
Market Cap
616.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 393.19B | 37.32B | 10.49% |
Dec 31, 2022 | 355.87B | 64.34B | 22.07% |
Dec 31, 2021 | 291.53B | 61.78B | 26.89% |
Dec 31, 2020 | 229.75B | -22.84B | -9.04% |
Dec 31, 2019 | 252.59B | 66.27B | 35.57% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanmi Science | 1,283.65B |
Hanall Biopharma | 134.24B |